Format

Send to

Choose Destination
See comment in PubMed Commons below
J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1295-8.

Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.

Author information

1
Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0111, USA. nestler@hsc.vcu.edu

Abstract

Evidence suggests that some actions of insulin are mediated by putative inositolphosphoglycan (IPG) mediators, also known as second messengers. We review studies indicating that the IPG signaling system transduces insulin's stimulation of human thecal androgen biosynthesis, thus offering a mechanism by which insulin can stimulate ovarian androgen production even in women with PCOS whose tissues are resistant to insulin's stimulation of glucose metabolism. Furthermore, a deficiency in a specific D-chiro-inositol-containing IPG may contribute to insulin resistance in women with PCOS. In support of this idea, administration of D-chiro-inositol has been demonstrated to improve glucose tolerance, decrease serum androgens and improve ovulation in PCOS. The hypothesis is advanced that PCOS may be characterized by a defect in the conversion of myo-inositol to D-chiro-inositol, and that such a defect would contribute to both insulin resistance and hyperandrogenism in the syndrome.

PMID:
11117673
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center